• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Introduction to 6-bromo-3-nitropyridin-2-amine hydrobromide (CAS No. 219767-18-7)

6-bromo-3-nitropyridin-2-amine hydrobromide, with the chemical identifier CAS No. 219767-18-7, is a significant compound in the realm of pharmaceutical and agrochemical research. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse biological activities and utility in medicinal chemistry. The structural features of this molecule, including the presence of both bromine and nitro substituents, make it a valuable intermediate in the synthesis of more complex molecules.

The bromo and nitro functional groups in 6-bromo-3-nitropyridin-2-amine hydrobromide play crucial roles in its reactivity and potential applications. The bromine atom, being an electron-withdrawing group, can influence the electronic properties of the pyridine ring, making it more susceptible to nucleophilic substitution reactions. On the other hand, the nitro group introduces a strong electron-withdrawing effect through resonance, which can modulate the reactivity of adjacent positions on the ring. These features make this compound a versatile building block for further chemical modifications.

In recent years, there has been growing interest in developing novel therapeutic agents based on pyridine derivatives. The amine moiety in 6-bromo-3-nitropyridin-2-amine hydrobromide provides a site for further functionalization, allowing chemists to explore various pharmacophores. This has led to its use in the synthesis of potential drug candidates targeting a range of diseases, including cancer, infectious diseases, and neurological disorders.

One of the most promising areas of research involving 6-bromo-3-nitropyridin-2-amine hydrobromide is its application in oncology. Pyridine derivatives have shown significant promise as kinase inhibitors, particularly in targeting tyrosine kinases that are overexpressed in cancer cells. The structural motifs present in this compound can be tailored to interact with specific binding pockets on these kinases, leading to the development of potent and selective inhibitors. Several studies have demonstrated that derivatives of this compound exhibit inhibitory activity against various kinases, making them attractive candidates for further development.

Moreover, the hydrobromide salt form of 6-bromo-3-nitropyridin-2-amine hydrobromide enhances its solubility and stability, which are critical factors for pharmaceutical applications. This salt form ensures that the compound remains stable under various storage conditions and can be easily formulated into drug products. The improved solubility also facilitates its use in drug delivery systems, allowing for more efficient administration and absorption.

Recent advancements in computational chemistry have also contributed to a deeper understanding of the pharmacological properties of 6-bromo-3-nitropyridin-2-amine hydrobromide. Molecular modeling studies have helped researchers predict how this compound interacts with biological targets at the molecular level. These insights have guided the design of more effective derivatives with enhanced binding affinity and selectivity. Additionally, virtual screening techniques have been employed to identify new analogs with improved pharmacokinetic profiles.

The agrochemical industry has also recognized the potential of 6-bromo-3-nitropyridin-2-amine hydrobromide as a key intermediate in the synthesis of novel pesticides and herbicides. Pyridine-based compounds are known for their efficacy in protecting crops from pests and diseases. By modifying the structure of this compound, chemists can develop agrochemicals that are more environmentally friendly and less toxic to non-target organisms. This aligns with the growing demand for sustainable agricultural practices worldwide.

In conclusion, 6-bromo-3-nitropyridin-2-amine hydrobromide (CAS No. 219767-18-7) is a multifaceted compound with significant potential in pharmaceutical and agrochemical applications. Its unique structural features, combined with its reactivity and solubility characteristics, make it a valuable tool for researchers exploring new therapeutic agents and sustainable agricultural solutions. As our understanding of its properties continues to evolve, we can expect to see even more innovative applications emerging from this versatile compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)